Study on the Effects of National Volume‐Based Procurement of Chemical Drugs on Chinese Patent Medicines: Lipid‐Lowering Drugs as an Example

Documenti analoghi

• “Walls Around Cells”—Food and Drug Administration's Recent Decoupling Policies Fragment Open Science and Undermine Global Health
  di: Liangbin Zhou, et al.
  Pubblicazione: (2025)
• Challenges and Solutions in Deploying Systematized Nomenclature of Medicine—Clinical Terms in the Chinese Healthcare Context
  di: Ge Wu, et al.
  Pubblicazione: (2026)
• Status and Factors Associated With Patient Safety Culture in Traditional Chinese Medicine Institutions: A Cross‐Sectional Study
  di: Liujin Zhang, et al.
  Pubblicazione: (2025)
• Evaluating the Effects of Psychosocial, Medical and Competence Approaches of Drug Treatment and Rehabilitation: A Secondary Data Analysis
  di: Tingyu Luo, et al.
  Pubblicazione: (2026)
• Awareness, Knowledge, and Acceptance of Living Wills Among Chinese Cancer Patients: A Cross‐Sectional Study
  di: Longxia Hu, et al.
  Pubblicazione: (2025)